Busse, P.J., Christiansen, S.C., Riedl, M.A., et al. (2021) US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema. The Journal of Allergy and Clinical Immunology: In Practice, 9, 132-150.e3.
https://doi.org/10.1016/j.jaip.2020.08.046

has been cited by the following article:

• TITLE: Hereditary Angioedema in Pregnancy and Management without Recombinant Human C1-INH

  AUTHORS: Natália Paseto Pilati, Maria Alexandrina Zanatta, Daniele Camila Maltauro, Gabrielle Behenck, Edimárlei Gonsales Valério, Fernanda Oliveira Castilhos, Eduardo Vettorazzi-Stuczynski, Daniela Vanessa Vettori, Janete Vettorazzi

  KEYWORDS: Hereditary Angioedema (HAE), C1-Inhibitor, High-Risk Pregnancy, Prophylaxis

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.11 No.11, November 11, 2021

  ABSTRACT: A pregnant woman diagnosed with type 1 angioedema seeks care at a public hospital for planning the delivery. This report presents ways to prevent and manage an acute HAE crisis during childbirth and early postpartum without the availability of first-line medications, such as plasma-derived human C1-INH concentrate.